The most studied NAFLD-related serum biomarker is the hepatocyte apoptosis product, cytokeratin-18 (CK-18) [11, 12], accounting for about 5% of liver proteins [13]. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatotic liver disease.